LithiumBank Resources

MEDICAL MARIJUANA (OTCMKTS: MJNA) STOCK QUOTE

Last Trade: US$0.002 -0.0001 -4.76
Volume: 1,954,448
5-Day Change: -1.00%
YTD Change: -1.00%
Market Cap: US$6.880M

LATEST NEWS FROM MEDICAL MARIJUANA

World’s First-Ever Publicly Traded Cannabis Company Appoints Longtime Board Member as New CEO SAN DIEGO, CA , March 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), a holding company with operating assets dedicated to the cannabis and hemp industries, along with portfolio investments in companies in the biotechnology industry, announced today the appointment of Dr. Timothy... Read More
Study Carried Out by Center for Research and Advanced Studies of the IPN and the Siglo XXI National Medical Center Show Advantages of Oral Administration of CBD to Reduce Levels of Neuronal Death in Animal Model SAN DIEGO, CA, Feb. 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s... Read More
New Products Offer 3,000mg to 6,000mg, Will Come in Jars of 30 and 60mL, Presenting Significant Cost Savings to Rapidly Growing Brazil Market SAN DIEGO, CA, Jan. 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply... Read More
Direct Selling Subsidiary Taps Network Marketing Legends to Lead Communication and Information Technologies as Company Continues International Expansion SAN DIEGO, CA, Nov. 29, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands,... Read More
SAN DIEGO, CA, Nov. 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today its financial results for the quarter ending September 30, 2022, and provided an overview of recent operational... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary HempMeds® Brasil has been featured across several major press outlets in Brazil including an interview with Folha de S. Paulo, the largest newspaper in the country,... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today the accomplishments made through a successful sponsorship that its subsidiary HempMeds® Mexico fulfilled at the XII Latin American Congress of Epilepsy in Medellín, Colombia, in early... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary HempMeds® Mexico collaborated with experts from the Meritorious Autonomous University of Puebla, Mexico, and the Autonomous University of Barcelona, Spain, in... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that it has entered into an Asset Purchase Agreement with MFINITY Global LLC, a direct-selling organization focused on promoting natural health and a rewarding sales model. Additionally,... Read More
Global Cannabis Company Expands Supply Chain in Europe through Agreement with Complete Hemp Technologies Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary, Kannaway, has signed a distribution agreement with long-time... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced its financial results for the quarter ending June 30, 2022, and provided an overview of recent operational highlights. Second Quarter 2022 Financial and Operational Highlights ● Generated $7.8... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today its pharmaceutical subsidiary, HM Pharma , has submitted a product dossier for its cannabidiol (CBD) products after receiving Sanitary Authorization from ANVISA, Brazil’s Health... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its CEO Blake Schroeder has published an article in Nasdaq News to provide the industry with insight on the future of federal cannabis legalization in the U.S. In his article... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary HempMeds® Brasil has established a new health and wellness-focused podcast PodioCast and, as a result, has been featured in several top news publications in Brazil... Read More
Medical Marijuana, Inc. ( OTC: MJNA ) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that in June its subsidiary Kannaway® has achieved its largest revenue month in the Company’s history for its Japan division. Kannaway® established operations in Japan in 2019 and the... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”) , the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary HempMeds® is collaborating with Hospital del Cruce to conduct the first study in Argentina on the efficiency of CBD as a treatment for epilepsy in adults. The... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway® will be hosting its South Africa Regional Conference in Cape Town this Saturday, July 2, 2022. “Kannaway has experienced an incredible start in South Africa... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that in May its subsidiary Kannaway® has achieved its largest revenue month in the company’s history for its Japan division. According to one of the most recent industry reports, Japan’s... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that it applauds the Ninth U.S. Circuit Court of Appeals for deeming Delta-8 THC, a compound found in hemp, to be federally legal under the 2018 Farm Bill. In celebration of this... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that it has launched its first pharmaceutical subsidiary, HM Pharma , in Brazil. “We have been working hard to connect and build meaningful relationships with medical professionals and... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary HempMeds® Brasil was featured in Forbes on its recent successes. The article titled, “The Steps of Cannabis in Brazil” details how HempMeds® Brasil has grown 50% year... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today its financial results for the quarter ending March 31, 2022, and provided an overview of recent operational highlights. First Quarter 2022 Financial and Operational Highlights Generated... Read More
Medical Marijuana, Inc . (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway® has participated in the industry -led cannabidiol (CBD) Safety Study and that its preliminary results, released this week, are overwhelmingly positive for... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that in April, the Company has achieved its largest revenue month of 2022 and its subsidiary Kannaway® has achieved its largest revenue month in the company’s history in its Japan... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway® is welcoming direct sales veteran Eric Glenn as a Kannaway® Entrepreneur. “We are very excited to have Eric join our team of talented Entrepreneurs and know... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its CEO Blake Schroeder was named the winner of a Silver Stevie® Award in the Achievement in Management - Consumer Products category in The 20th Annual American Business Awards®.... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today growth milestones in its HempMeds® Brasil business segment, where the subsidiary is growing at a rate 75.8% faster than that of the country’s entire market, which continues to double in... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway® achieved its largest revenue month in the company’s history in its South Africa division in March 2022. Africa’s cannabis industry is rapidly expanding,... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, is pleased to provide a corporate update on its pharmaceutical investments targeting novel therapies for unmet medical needs in large and rare disease markets. “As a ‘Company of Firsts, Medical... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that the Company’s Chief Financial and Information Officer, Todd Morrow, has been promoted and will now serve as the Company’s President. Prior to joining the Company, Morrow, who has... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway® has opened a distribution center in Hong Kong. “Hemp has a long history in Hong Kong and throughout China,” ​​said Kannaway® CEO Blake Schroeder. “We hope... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway® has hired Jeanne Rawdin as the Company’s Global Communications Manager. Rawdin joins Kannaway® after establishing a successful career in broadcast... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway® has opened a new office and warehouse in Warsaw, Poland. The new 7,771 square foot warehouse is strategically positioned near the Warsaw airport and city... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway® Japan had its best revenue month in the Company’s history in December 2021. According to Research and Markets, the global CBD oil market is expected to... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway® Japan had its best revenue month in the Company’s history in November 2021. “We’ve experienced tremendous growth and success in Japan this quarter,” said... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway® has hired Jose Miguel Gutierrez Vazquez as Sales Director of its Mexico operations. “2021 has been an exciting year for us as we have added pedigreed... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its CEO Blake Schroeder was featured on an episode of Seeking Alpha’s CEO Interviews podcast discussing the current landscape of cannabis stocks. The November 17, 2021 episode... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway® has initiated efforts to expand its operations to South Africa and has hired Duduzile Mathole as Country Manager, South Africa. The cannabidiol (CBD) market... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today financial results for the quarter ending September 30, 2021, and provided an overview of recent operational highlights. Third Quarter 2021 Financial and Operational Highlights ●... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that the Company’s subsidiary Kannaway® has promoted its Japan Division General Manager, Peter Dale, to Global Chief Sales Officer. ​​As Global Chief Sales Officer, Peter Dale will be... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company’s subsidiary Kannaway® has won a historic court case in Finland proving the legality of the importation of the Company’s cannabidiol (CBD) oil. “We have been a leader in... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company’s subsidiary Kannaway® has received a Gold Globee® Award in the 2021 CEO Awards for Executive Achievement of the Year in the Consumer Products category. Globee® Awards’... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has hired Peter J.E. Verdegem, Ph.D., MSc, MBA, as the Company’s Vice President of North America, German Speaking Countries & Product Development. “In... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has hired Lennon Ledbetter to become the Company’s Vice President of Sales. “A company is only as strong as its executive team and we look forward to... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Japanese division of the Company’s subsidiary Kannaway® experienced its largest revenue month in the division’s history for the month of September 2021. Medical Marijuana Inc.’s... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway ® will partner with the non-profit organization The Por Grace Foundation . The partnership will be focused on raising awareness of the many potential benefits... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company’s subsidiary Kannaway® has launched its operations in Hong Kong. ​​"Our first Asian expansion has been a fantastic success in Japan and we now look forward to bringing... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company’s CEO Blake Schroeder was featured in Industry Era magazine discussing the current landscape of the hemp-based cannabidiol (CBD) industry and the Company’s recent... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today financial results for the quarter ending June 30, 2021, and provided an overview of recent operational highlights. Second Quarter 2021 Financial and Operational Highlights ● Generated... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company’s subsidiaries HempMeds® Mexico and Kannaway® Japan , as well as Medical Marijuana, Inc.’s third-party manufacturing and distribution business, each achieved their... Read More
Medical Marijuana, Inc . (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has been approved to join two of the leading hemp industry organizations in Japan, Hokkaido Industrial Hemp Association (HIHA) and Association for Japan... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® has released a brand new product to complement its extensive product line, broad-spectrum cannabidiol (CBD)-infused gummies. HempMeds® gummies are... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Latin American operations of its subsidiary HempMeds® achieved its best revenue month ever in the history of the Company in June 2021. In Latin America, the Company increased its... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® applauds Mexico’s Supreme Court for its decision to deem a set of laws which criminalized the recreational adult use of cannabis in Mexico unconstitutional,... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company’s subsidiary HempMeds® is excited to welcome five-time Brazilian national wrestling champion and professional UFC fighter Raoni Barcelos as its newest spokesperson for... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”) announced today that it has appointed Blake Schroeder as Chairman of the Board and named him as Chief Executive Officer and President of the Company. Mr. Schroeder replaces Dr. Stuart Titus in those roles. Dr. Titus resigned from these positions in order to move towards semi-retirement. Dr. Titus will continue to serve the Company in a consulting role as an exclusive... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today financial results for the quarter ending March 31, 2021, and provided an overview of recent operational highlights. “Our operations made tremendous advancements in the first quarter of... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company and its subsidiaries received two prestigious Stevie® Awards in The 19th Annual American Business Awards®, the U.S.A.’s premier business awards program. Notably, Medical... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® Brasil had its best revenue month ever in Company history in April 2021. “Our HempMeds Brasil operations have seen a consistent increase over the years. We... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company’s CEO Dr. Stuart Titus will be presenting virtually at a cannabis investing conference, the 2021 Sequire Cannabis Conference, on Tuesday, April 20, at 1 p.m. EDT/10 a.m.... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today financial results for the quarter and year ending Dec. 31, 2020, and provided an overview of recent operational highlights. "While the entire world felt the impact of 2020, I could not be... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® is proud to welcome X Games world record-holding skateboarder Italo Penarrubia as its newest brand ambassador. "We are excited to bring Penarrubia on as a... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, reports today that its subsidiary Kannaway® participated in, and today announces the recent positive results, of the Validcare clinical study. The study used Kannaway®’s hemp-derived cannabidiol (CBD)... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® applauds Mexico’s Chamber of Deputies for approving a bill to federally legalize marijuana. “At HempMeds Mexico, we have watched both regulations and public... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Japanese division of its subsidiary Kannaway® had its best sales month ever in Company history in February 2021. “When we first entered the Japanese market in late 2019, we were... Read More
Pure Gold Recognized as Free of Substances Banned by US Anti-Doping Agency (USADA) and Professional Sports Leagues Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has received Certified Drug Free approval... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has submitted its Novel Foods application for its cannabidiol (CBD) products to the UK’s Food Standards Agency (FSA) through the European Industrial Hemp... Read More
One World Universe Inc . (OTC: OWUV), a publicly traded company that invests in business opportunities within emerging industries and provides humanitarian efforts in over 185 countries, has announced it is in negotiations with HempMeds ® , a subsidiary of Medical Marijuana, Inc. (OTC: MJNA) which will enhance One World’s medicinal product pipeline being distributed throughout their emerging 3rd world network. Jerry C.... Read More
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has launched several new products in the U.S. and Europe as part of the Company’s 2021 Focus Virtual Kickoff Event. These newly launched products include the... Read More

COPYRIGHT ©2022 GREEN STOCK NEWS